In the literature, inhibition of MARCKS using MPS (MARCKS phosphorylation site domain) peptide showed promising results in different cancers with inhibition of tumor growth and metastases in vivo [13,14], but no study was reported in breast cancer. The gene discussed is MARCKS; the disease is neoplasm.